Detalhe da pesquisa
1.
An observational, multicentre study of cabazitaxel in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (CAPRISTANA).
BJU Int
; 123(3): 456-464, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30098093
2.
Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate.
Cancer Med
; 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38164124
3.
Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience.
Anticancer Res
; 43(1): 463-471, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36585174